Alnylam Pharmaceuticals | Actif À Court Terme



Current Assets Changement Date
Acadia Pharmaceuticals USD 938.32M 150.03M 2024-12
Agios Pharmaceuticals USD 965.6M 108.59M 2024-12
Alnylam Pharmaceuticals USD 3.3B 60.14M 2024-12
Amgen USD 29.03B 2.26B 2024-12
Arrowhead Research USD 570.54M 124.93M 2024-12
BioMarin Pharmaceutical USD 3.23B 175.84M 2024-12
Incyte USD 3.24B 430.32M 2024-12
Ionis Pharmaceuticals USD 2.62B 93.56M 2024-12
Moderna USD 8.1B 1.57B 2024-12
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Novartis USD 29.7B 1.56B 2024-12
PTC Therapeutics USD 1.37B 83.98M 2024-12
Regeneron Pharmaceuticals USD 27.21B 7.88B 2024-12
Sanofi 30.08B 589M 2024-06
Sarepta Therapeutics USD 3.07B 388.09M 2024-12
Takeda JPY 2.75T 299.73B 2024-12
Tectonic Therapeutic USD 162.6M 24.79M 2024-09
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12
Xencor USD 577.6M 4.27M 2024-12



Alnylam Pharmaceuticals Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.